Physician profile
Jayme Fuller
NPI 1306490446
$3,023.83
in general payments reported to CMS, 2019-2025
12 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.08 · 2022: $418 · 2023: $2,132 · 2024: $159 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,912 · Food and Beverage: $518 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,911.91 |
| Food and Beverage | $517.85 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,421.72 | 2022-2025 | Stratafix, Surgicel Nu-Knit |
| Stryker Corporation | $127.10 | 2021-2022 | |
| Ethicon US, LLC | $100.00 | 2022-2023 | Vistaseal |
| Kci USA, INC. | $91.19 | 2022 | |
| Solventum Corporation | $88.25 | 2024 | V.A.C. Granufoam, V.A.C.Instill, Prevena |
| Convatec INC. | $64.50 | 2025 | |
| Becton, Dickinson and Company | $26.26 | 2024 | Arista Ah Flexitip |
| Depuy Synthes Sales INC. | $25.88 | 2025 | Na |
| Smith+Nephew, INC. | $24.32 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Pacira Pharmaceuticals Incorporated | $20.55 | 2024 | Exparel |
| Tactile Systems Technology INC | $19.17 | 2023 | Entre Plus, Flexitouch Plus |
| Bioventus LLC | $14.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayme Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.